Ultrasuoni Diagnostic Medical Center, 95100 Catania, Italy.
Department of Mathematics and Statistics "S. Vianelli", University of Palermo, viale delle Scienze, 90128 Palermo, Italy.
Biomed Res Int. 2014;2014:365982. doi: 10.1155/2014/365982. Epub 2014 Mar 4.
In our study, we evaluated the feasibility of a new sampling method for splenic stiffness (SS) measurement by Quantitative Acoustic Radiation Force Impulse Elastography (Virtual Touch Tissue Quantification (VTTQ)).We measured SS in 54 patients with HCV-related cirrhosis of whom 28 with esophageal varices (EV), 27 with Chronic Hepatitis C (CHC) F1-F3, and 63 healthy controls. VTTQ-SS was significantly higher among cirrhotic patients with EV (3.37 m/s) in comparison with controls (2.19 m/s, P<0.001), CHC patients (2.37 m/s, P<0.001), and cirrhotic patients without EV (2.7 m/s, P<0.001). Moreover, VTTQ-SS was significantly higher among cirrhotic patients without EV in comparison with both controls (P<0.001) and CHC patients (P<0.01). The optimal VTTQ-SS cut-off value for predicting EV was 3.1 m/s (AUROC=0.96, sensitivity 96.4%, specificity 88.5%, positive predictive value 90%, negative predictive value 96%, positive likelihood ratio 8.36, and negative likelihood ratio 0.04). In conclusion, VTTQ-SS is a promising noninvasive and reliable diagnostic tool to screen cirrhotic patients for EV and reduce the need for upper gastrointestinal endoscopy. By using our cut-off value of 3.1 m/s, we would avoid endoscopy in around 45% of cirrhotic subjects, with significant time and cost savings.
在我们的研究中,我们评估了一种新的脾脏硬度(SS)测量采样方法(定量声辐射力脉冲弹性成像(虚拟触摸组织定量(VTTQ)))的可行性。我们测量了 54 例丙型肝炎相关肝硬化患者的 SS,其中 28 例有食管静脉曲张(EV),27 例慢性丙型肝炎 C(CHC)F1-F3,63 例健康对照者。与对照组(2.19m/s,P<0.001)、CHC 患者(2.37m/s,P<0.001)和无 EV 的肝硬化患者(2.7m/s,P<0.001)相比,EV 肝硬化患者的 VTTQ-SS 显著升高。此外,与对照组(P<0.001)和 CHC 患者(P<0.01)相比,无 EV 的肝硬化患者的 VTTQ-SS 显著升高。预测 EV 的最佳 VTTQ-SS 截断值为 3.1m/s(AUROC=0.96,灵敏度 96.4%,特异性 88.5%,阳性预测值 90%,阴性预测值 96%,阳性似然比 8.36,阴性似然比 0.04)。总之,VTTQ-SS 是一种很有前途的非侵入性和可靠的诊断工具,可用于筛查肝硬化患者的 EV,并减少上消化道内镜检查的需要。通过使用我们的 3.1m/s 截断值,我们可以避免约 45%的肝硬化患者进行内镜检查,从而节省大量的时间和成本。